UNSPSC 51373316: Acetaminophen/propoxyphene

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373316 Acetaminophen/propoxyphene is a Commodity code that in recent state and local solicitations captures pharmaceuticals and over-the-counter products procured for public health, community health programs, and state employee and retiree benefit plans. State and local buyers under this code include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances serving participating jurisdictions. The work being solicited ranges from direct purchases of specific pharmaceutical products (naloxone and safe drug deactivation systems for community health initiatives) to large-scale framework agreements for generic pharmaceuticals and OTC products distributed through authorized wholesalers to multiple public facilities across participating states.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries due by July 26, 2023—a competitive invitation to bid for fixed-fee supplies with a two-year initial term and one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels, signaling exploratory procurement design ahead of formal competitive solicitation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) with contract awards effective July 1, 2026, and available to participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions.